Isofol Medical
0.67 SEK
-0.74 %
Less than 1K followers
ISOFOL
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Isofol Medical
EV/S
Median 2020-2023
EV/EBIT
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 10.08 | 19.45 | 8.12 | 0.65 | 0.64 | 1.95 | 0.73 |
| Shares | 64.5 | 120.0 | 183.8 | 183.8 | 183.8 | 183.8 | 281.1 |
| Market cap | 650.2 | 2,334.2 | 1,492.4 | 119.5 | 117.9 | 358.6 | 204.9 |
| Enterprise value | 526.0 | 2,219.3 | 1,114.6 | -68.6 | -20.2 | 265.4 | 77.9 |
| EV/S | - | 59.8 | 49.7 | neg. | neg. | - | - |
| EV/EBITDA | neg. | neg. | neg. | 0.4 | 0.5 | neg. | neg. |
| EV/EBIT | neg. | neg. | neg. | 0.4 | 0.5 | neg. | neg. |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 6.20 | 35.07 | 4.69 | 0.75 | 0.97 | 4.60 | 1.90 |
| P/S | - | 62.9 | 66.6 | 9.3 | 163.8 | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 71.6 % | 44.9 % | 79.3 % | 74.2 % | 86.4 % | 79.2 % | 83.4 % |
| Gearing ratio | 2.6 % | 2.2 % | 0.5 % | 1.5 % | - | - | - |